Epidemiology of invasive meningococcal disease in Germany, 2002-2010, and impact of vaccination with meningococcal C conjugate vaccine

Journal of Infection

Volumn 66, Issue 1, 2013, Pages 48-56

  Hellenbrand, Wiebke ^a   Elias, Johannes ^b   Wichmann, Ole ^a   Dehnert, Manuel ^a   Frosch, Matthias ^b   Vogel, Ulrich ^b  

^a ROBERT KOCH INSTITUTE   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Germany; Invasive meningococcal disease; Meningococcal C vaccination; Strain characterization; Surveillance

Indexed keywords

MENINGOCOCCUS VACCINE;

AGE DISTRIBUTION; ARTICLE; BACTERIAL STRAIN; FATALITY; GEOGRAPHIC DISTRIBUTION; GERMANY; HUMAN; INCIDENCE; MENINGOCOCCOSIS; TREND STUDY; VACCINATION;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; GERMANY; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MENINGOCOCCAL INFECTIONS; MENINGOCOCCAL VACCINES; MIDDLE AGED; NEISSERIA MENINGITIDIS;

EID: 84870765549     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2012.09.008     Document Type: Article

References (28)

1. European Centre for Disease Prevention and Control Surveillance of invasive bacterial diseases in Europe 2008/2009 2011, ECDC, Stockholm.
2. Buysse C.M.P., Raat H., Hazelzet J.A., Hulst J.M., Cransberg K., Hop W.C.J., et al. Long-term health status in childhood survivors of meningococcal septic shock. Arch Pediatr Adolesc Med 2008, 162(11):1036-1041.
3. Robert Koch-Institute Zur Situation bei ausgewählten Infektionkrankheiten in Deutschland: invasive Meningokokken-Erkrankungen im Jahr 2007. Epidemiol Bull 2008, 32:265-272.
4. Sächsische Impfkommission Sachsische Impfkommission beschließt Einführung der Varizellen- und Meningokokkenimpfung C als Standardimpfung. Ärztebl Sachsen 2003, 8(357):360.
5. Ständige Impfkommission am Robert Koch-Institut Begründung der STIKO-Empfehlungen zur Impfung gegen Pneumokokken und Meningokokken vom Juli 2006. Epidemiol Bull 2006, 31:260-267.
6. Ständige Impfkommission am Robert Koch-Institut Mitteilung der Ständigen Impfkommission am Robert Koch-institut: Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-institut/stand: Juli 2006. Epidemiol Bull 2006, 30:235-254.
7. Bundesministerium für Gesundheit Gesetzliche Krankenversicherung Mitglieder, mitversicherte Angehörige und Krankenstand Jahresdurchschnitt 2010 2011, [cited 2011 Dec 5]. http://www.bmg.bund.de/fileadmin/dateien/Downloads/Statistiken/GKV/Mitglieder__Versicherte/KM1_Jahresdurchschnitt_2010.pdf.
8. Elias J., Health office in the rural district office wartburgkreis, Claus H., Frosch M., Vogel U. Evidence for indirect nosocomial transmission of Neisseria meningitidis resulting in two cases of invasive meningococcal disease. J Clin Microbiol 2006, 44(11):4276-4278.
9. Maiden M.C.J., Bygraves J.A., Feil E., Morelli G., Russell J.E., Urwin R., et al. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci U S A 1998, 95(6):3140-3145.
10. Hunter P.R., Gaston M.A. Numerical index of the discriminatory ability of typing systems: an application of Simpson's index of diversity. J Clin Microbiol 1988, 26(11):2465-2466.
11. Grundmann H., Hori S., Tanner G. Determining confidence intervals when measuring genetic diversity and the discriminatory Abilities of typing methods for microorganisms. J Clin Microbiol 2001, 39(11):4190-4192.
12. Robert Koch-Institute Impfquoten bei den Schuleingangsuntersuchungen in Deutschland 2009. Epid Bull 2011, 16:125-129.
13. Schrauder A., Claus H., Elias J., Vogel U., Haas W., Hellenbrand W. Capture-recapture analysis to estimate the incidence of invasive meningococcal disease in Germany, 2003. Epidemiol Infect 2006, 135(4):1-8.
14. Robert Koch-Institute Invasive Meningokokken-Erkrankungen: Retrospektive Erhebung von Verdachtsmeldungen nach § 6 ABs. 1 IfSG Deutschland, 2001-2007. Epid Bull 2009, (8):69-75.
15. Brehony C., Jolley K.A., Maiden M.C.J. Multilocus sequence typing for global surveillance of meningococcal disease. FEMS Microbiol Rev 2007, 31(1):15-26.
16. Trotter C.L., Ramsay M.E. Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines. FEMS Microbiol Rev 2007, 31(1):101-107.
17. de Greeff S.C., de Melker H.E., Spanjaard L., Schouls L.M., van D.A. Protection from routine vaccination at the age of 14 months with meningococcal serogroup C conjugate vaccine in the Netherlands. Pediatr Infect Dis J 2006, 25(1):79-80.
18. Maiden M., Ibarz-Pavon A., Urwin R., Gray S., Andrews N., Clarke S., et al. Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity. JID 2008, 197(5):737-743.
19. Christensen H., May M., Bowen L., Hickman M., Trotter C.L. Meningococcal carriage by age: a systematic review and meta-analysis. Lancet Infect Dis 2010, 10(12):853-861.
20. Soriano-Gabarró M., Wolter J., Hogea C., Vyse A. Carriage of Neisseria meningitidis in Europe: a review of studies undertaken in the region. Expert Rev Anti Infect Ther 2011, 9(9):761-774.
21. Campbell H., Andrews N., Borrow R., Trotter C., Miller E. Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of Protection, and modeling predictions of the duration of herd immunity. Clin Diagn Lab Immunol 2010, 17(5):840-847.
22. Larrauri A., Cano R., Garcia M., de Mateo S. Impact and effectiveness of meningococcal C conjugate vaccine following its introduction in Spain. Vaccine 2005, 23(32):4097-4100.
23. Theeten H., Van Damme P., Carion F., Van Looveren M. Vaccinatie tegen meningokokken C in België. Kroniek en context van een federaal-regionale campagne. Tijdschrift Voor Geneeskunde 2003, 59(20):1239-1251.
24. Claus H., Maiden M.J.C., Wilson D.J., McCarthy N.D.J., Urwin R., Hessler F., et al. Genetic analysis of meningococci carried by children and young adults. J Infect Dis 2005, 191:1263-1271.
25. Perrett K.P., Winter A.P., Kibwana E., Jin C., John T.M., Yu L.M., et al. Antibody persistence after serogroup C meningococcal conjugate immunization of United Kingdom primary-school children in 1999-2000 and response to a booster: a phase 4 clinical trial. Clin Infect Dis 2010, 50(12):1601-1610.
26. Trotter C.L., Gay N.J., Edmunds W.J. The natural history of meningococcal carriage and disease. Epidemiol Infect 2006, 134(3):556-566.
27. Thulin-Hedberg S., Törös B., Fredlund H., Olcén P., Mölling P. Genetic characterisation of the emerging invasive Neisseria meningitidis serogroup Y in Sweden, 2000 to 2010. Euro Surveill 2011, 16(23). pii=19884.
28. Panatto D., Amicizia D., Lai P.L., Gasparini R. Neisseria meningitidis B vaccines. Expert Rev Vaccines 2011, 10(9):1337-1351.